What Happened this week? Cellectis’ CEO, Rare Disease, CRISPR

05/12/2015 - 1 minute

Monday: Cellectis CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”

Tuesday: Rare Diseases: Still a ‘Blue Ocean’ for Biotechs?

Wednesday: Crops Successfully Edited with CRISPR have no Transgenes! Is this Still GMO?

Thursday: History of Biotech: How the “First” Biotech Patent Generated Millions

Friday: Black Friday Ruin as TWO Biotechs Fail in Phase III Trials

Week-end: Christmas is coming … We have our “traditional” German Christmas Plant

christmas_plant_germany2

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member